US81663L1017 - Common Stock
San Diego, CA -- (SBWIRE) -- 02/08/2023 -- An investigation was announced for current long-term investors in shares of Sema4 Holdings Corp. (NASDAQ: SMFR) concerning potential breaches of fiduciary duties by certain directors of Sema4 Holdings Corp.
Sema4 Holdings (SMFR) rose ~7% after the company said it has its changed name and ticker symbol and issued higher Y/Y 2022 revenue guidance.
Sema4|GeneDx President & Chief Executive Officer, Katherine Stueland, to deliver presentation
Sema4|GeneDx President & Chief Executive Officer, Katherine Stueland, to deliver presentation...
Data underscores the value of mitochondrial DNA testing and the opportunity to improve health outcomes for critically ill newborns with early medical...
Data underscores the value of mitochondrial DNA testing and the opportunity to improve health outcomes for critically ill newborns with early medical intervention
Sema4 press release (SMFR): Q3 GAAP EPS of -$0.20 beats by $0.10.Revenue of $83.23M (+92.8% Y/Y) beats by $15.49M.Adjusted gross margin in the third quarter of 2022 was 20%, with...
Company will focus on its high growth, high margin pediatric and rare disease business, powered by whole exome/genome diagnostic testing and analysis and...
San Diego, CA -- (SBWIRE) -- 11/09/2022 -- The Shareholders Foundation announced that a deadline is coming up on November 7, 2022 in the lawsuit filed for certain investors of Sema4 Holdings Corp. (NASDAQ:SMFR).
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- Attention Sema4 Holdings, Corp. ("Sema4 Holdings Corp.") (NASDAQ: SMFR) shareholders: The Law Offices of Vincent Wong announce that a class...
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW)...
STAMFORD, Conn., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced it will release financial results for...
/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Sema4 Holdings, Corp. (NASDAQ:...
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sema4 Holdings, Corp. ("Sema4 Holdings Corp." or the "Company") (NASDAQ: SMFR) of a class action...
/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Sema4 Holdings, Corp. (NASDAQ: SMFR)...
Guideline adoption can help end the diagnostic odyssey experienced by many families
Guideline adoption can help end the diagnostic odyssey experienced by many families...
/PRNewswire/ -- Attention Sema4 Holdings, Corp. ("Sema4 Holdings Corp.") (NASDAQ: SMFR) shareholders: The Law Offices of Vincent Wong announce that a class...
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.